Please login to the form below

Not currently logged in
Email:
Password:

Brintellix

This page shows the latest Brintellix news and features for those working in and with pharma, biotech and healthcare.

EMA backs Lundbeck's Brintellix in depression

EMA backs Lundbeck's <b>Brintellix</b> in depression

EMA backs Lundbeck's Brintellix in depression. Drug recommended for approval to treat major depressive episodes in adults. ... In the latest round of EU drug recommendations, Lundbeck won backing for the use of Brintellix in the treatment of adult

Latest news

  • Lundbeck buoyed by <b>Brintellix</b> approval in US Lundbeck buoyed by Brintellix approval in US

    Lundbeck buoyed by Brintellix approval in US. FDA gives green light for to Cipralex/Lexapro successor in depression. ... Lundbeck was celebrating yesterday after the FDA approved its new antidepressant Brintellix, a successor to the big-selling

  • Lundbeck and Takeda submit depression drug for US approval Lundbeck and Takeda submit depression drug for US approval

    Lundbeck and Takeda submit depression drug for US approval. Brintellix could help Lundbeck overcome loss of patent protection for Lexapro/Cipralex. ... Lundbeck's plans to find a replacement for its big-selling antidepressant Lexapro/Cipralex continue

  • Print health ad spend in US remains buoyant Print health ad spend in US remains buoyant

    Antidepressant Brintellix, launched late in 2013 by Takeda and Lundbeck, was the second most advertised drug in January.

  • Takeda pipeline hit by fasiglifam failure Takeda pipeline hit by fasiglifam failure

    Much now hangs on the success of this drug and a couple of other late-stage products, such as vortioxetine for depression ( licensed from Lundbeck) - recently approved as Brintellix in the US -

  • Profits down at Lundbeck as revenues slip Profits down at Lundbeck as revenues slip

    All eyes are on the performance of Cipralex successor Brintellix ( vortioxetine) - which was approved at the end of September - along with other recent launches, such as alcoholism therapy Selincro ( nalmefene) and ... Meanwhile, Selincro's first launch (

More from news
Approximately 3 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Bayer’s Barbara Jaszewski joins Lundbeck Bayer’s Barbara Jaszewski joins Lundbeck

    In addition, Lundbeck also has Brintellix ( vortioxetine) under review by the EMA, while a once-monthly version of schizophrenia drug Abilify ( aripiprazole) is also due to launch during 2013.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Waggener Edstrom

Waggener Edstrom’s global and European healthcare hub is based in London, and works with experienced teams across the globe; teams...

Latest intelligence

The changing regulatory environment
Code of practice changes are encouraging transparency in pharma/HCP relationships...
Online Physician Communities
Study highlights value of internet for doctors in Eastern Europe
Electronic direct mail is proving popular as online access increases...
England’s clinical commissioning landscape
Who are the real masters in the new NHS?...